mMed Patent Portfolio for mobile medication management

Licensing through New Directions Technology Consulting, LLC

mMed Patent Portfolio

The technology protected by the five issued U.S. patents in the mMed patent portfolio could significantly advance medication management, including the delivery of essential medical information not communicated today. These mHealth patents were issued by the USPTO between July 2010 and July 2012. The Israel and Australia patent offices have issued notices of allowance for patents extending protection of allowed claims from the United States to those two countries. A patent is pending in the E.U.

mMed Patent Portfolio

What is mHealth?

mHealth is the use of mobile and wireless devices to improve health outcomes, healthcare services and health research.

The definition was developed by a National Institutes of Health (NIH) Consensus group; the NIH is an agency of the U.S. Department of Health and Human Services.

Licensing Opportunities

New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio, which relates to technology that takes a comprehensive medication management program into “the wild,” wherever mobile patients are. New Directions can license the intellectual property or partner to develop a mobile medication management system based on the patents.

Note: mMed is a trademark of New Directions Technology Consulting, LLC. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.